Zimmer Biomet Holdings, Inc. (SWX:ZBH)
Switzerland · Delayed Price · Currency is CHF 72.00
+0.19 (0.27%)
At close: Sep 30, 2025
Zimmer Biomet Holdings Revenue
Zimmer Biomet Holdings had revenue of $2.08B USD in the quarter ending June 30, 2025, with 6.97% growth. This brings the company's revenue in the last twelve months to $7.83B, up 4.11% year-over-year. In the year 2024, Zimmer Biomet Holdings had annual revenue of $7.68B with 3.85% growth.
Revenue (ttm)
$7.83B
Revenue Growth
+4.11%
P/S Ratio
2.49
Revenue / Employee
$460.81K
Employees
17,000
Market Cap
15.51B CHF
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 7.68B | 284.40M | 3.85% |
| Dec 31, 2023 | 7.39B | 454.30M | 6.55% |
| Dec 31, 2022 | 6.94B | 112.60M | 1.65% |
| Dec 31, 2021 | 6.83B | 699.80M | 11.42% |
| Dec 31, 2020 | 6.13B | -1.85B | -23.24% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Roche Holding AG | 63.49B |
| Novartis AG | 43.89B |
| Lonza Group AG | 7.09B |
| Galderma Group AG | 3.73B |
| Alcon | 7.97B |
| Sandoz Group AG | 8.42B |
| Straumann Holding AG | 2.58B |
| Sonova Holding AG | 3.87B |
Zimmer Biomet Holdings News
- 5 days ago - Zimmer Biomet Announces Japan PMDA Approval of World's First Iodine-Treated Total Hip Replacement System - PRNewsWire
- 11 days ago - Stifel Maintains Buy Rating on Zimmer Biomet Holdings (ZBH), Raises Price Target | ZBH Stock News - GuruFocus
- 12 days ago - Zimmer Biomet Holdings (ZBH) Receives 'Buy' Rating from Rothschild & Co | ZBH Stock News - GuruFocus
- 14 days ago - How To YieldBoost Zimmer Biomet Holdings To 7.7% Using Options - Nasdaq
- 14 days ago - Insider Decision: Sang Yi Offloads $124K Worth Of Zimmer Biomet Holdings Stock - Benzinga
- 15 days ago - Insider Sell: Sang Yi Sells 1,200 Shares of Zimmer Biomet Holdings Inc (ZBH) - GuruFocus
- 15 days ago - Notable Two Hundred Day Moving Average Cross - ZBH - Nasdaq
- 22 days ago - Zimmer Biomet Holdings, Inc. (ZBH) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript) - Seeking Alpha